MURRAY RICHARD /CA/ 4
4 · Jounce Therapeutics, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
- Award
Common Stock
2022-02-01+87,500→ 273,077 total - Award
Stock Option (Right to Buy)
2022-02-01+175,000→ 175,000 totalExercise: $7.56Exp: 2032-02-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The option will vest quarterly in 16 equal installments following January 1, 2022.